Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

310
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

425
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
425
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

104
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
104
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

2
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

351
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
351

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Desacetyl-alpha-melanocyte stimulating hormone and alpha-melanocyte stimulating hormone are required to regulate energy balance" [Mol Metab 9 (2018) 207-216/29226825].

Molecular metabolism·2026
Same author

Use of TaqMan array card to investigate bacterial isolates in diabetic foot ulcers.

Journal of medical microbiology·2026
Same author

The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation.

Diabetologia·2026
Same author

The accessory protein MRAP2 directly interacts with melanocortin-3 receptor to enhance signaling.

Science signaling·2025
Same author

Cross-species studies implicate the melanocortin 3 receptor more strongly in the control of pubertal development than energy balance.

Molecular metabolism·2025
Same author

The importance of science communication surrounding weight-loss drugs.

The lancet. Diabetes & endocrinology·2025

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

3.1K

Obesity and FTO: Changing Focus at a Complex Locus.

Y C Loraine Tung1, Giles S H Yeo1, Stephen O'Rahilly1

  • 1Medical Research Council Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Cell Metabolism
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Common variants in the fat mass and obesity-associated (FTO) gene are linked to obesity. Recent studies suggest these variants affect neighboring IRX3 and RPGRIP1L genes, not FTO itself, offering new insights into obesity genetics.

More Related Videos

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

16.8K
High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster
08:28

High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster

Published on: September 13, 2017

12.2K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

3.1K
Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

16.8K
High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster
08:28

High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster

Published on: September 13, 2017

12.2K

Area of Science:

  • Genetics
  • Obesity Research
  • Molecular Biology

Background:

  • The fat mass and obesity-associated (FTO) gene is strongly linked to human obesity through common intronic variants.
  • Murine models with altered Fto expression demonstrate impacts on body weight and composition.
  • The precise mechanism connecting FTO variants to FTO activity remains unclear.

Purpose of the Study:

  • To review recent findings on the functional connections of obesity-associated single nucleotide polymorphisms (SNPs) within the FTO gene.
  • To explore the implications of these findings for understanding the genetic basis of obesity.

Main Methods:

  • Review of recent scientific literature and genetic association studies.
  • Analysis of functional data linking FTO variants to neighboring genes.
  • Consideration of genome-wide association study (GWAS) hit interpretation.

Main Results:

  • Obesity-associated SNPs in the FTO gene region appear functionally linked to the neighboring IRX3 and RPGRIP1L genes.
  • These connections suggest an indirect mechanism of FTO variant influence on obesity.
  • The direct role of FTO in mediating the effects of these common variants is questioned.

Conclusions:

  • Recent discoveries challenge the direct role of FTO in mediating obesity risk associated with intronic variants.
  • The functional impact of these variants may be exerted through regulatory effects on IRX3 and RPGRIP1L.
  • Future research on GWAS hits should consider the broader genomic context and interactions with neighboring genes.